TCM liver drug receives permit from US Food & Drug Administration

TCM liver drug in US breakthrough by Cai Wenjun 

A TRADITIONAL Chinese medicine developed in Shanghai has received a permit from the United States Food and Drug Administration to conduct clinical tests on American hepatitis C patients who have developed fibrosis….

—Inger

Tags: , ,

Comments are closed.